BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32991950)

  • 1. The VE-Cadherin/β-catenin signalling axis regulates immune cell infiltration into tumours.
    Zhao Y; Li J; Ting KK; Chen J; Coleman P; Liu K; Wan L; Moller T; Vadas MA; Gamble JR
    Cancer Lett; 2021 Jan; 496():1-15. PubMed ID: 32991950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF.
    Nottebaum AF; Cagna G; Winderlich M; Gamp AC; Linnepe R; Polaschegg C; Filippova K; Lyck R; Engelhardt B; Kamenyeva O; Bixel MG; Butz S; Vestweber D
    J Exp Med; 2008 Nov; 205(12):2929-45. PubMed ID: 19015309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell-Mediated Immunotherapy.
    Zhao Y; Ting KK; Li J; Cogger VC; Chen J; Johansson-Percival A; Ngiow SF; Holst J; Grau G; Goel S; Muller T; Dejana E; McCaughan G; Smyth MJ; Ganss R; Vadas MA; Gamble JR
    Cancer Res; 2017 Aug; 77(16):4434-4447. PubMed ID: 28655790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hnRNPA2/B1 Ameliorates LPS-Induced Endothelial Injury through NF-
    Chen Y; Tang D; Zhu L; Yuan T; Jiao Y; Yan H; Yu W
    Mediators Inflamm; 2020; 2020():6458791. PubMed ID: 32565727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of alpha-catenin in the VE-cadherin complex is required for efficient transendothelial migration of leukocytes.
    van Buul JD; van Alphen FP; Hordijk PL
    Int J Biol Sci; 2009 Nov; 5(7):695-705. PubMed ID: 19918298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urocortin increased LPS-induced endothelial permeability by regulating the cadherin-catenin complex via corticotrophin-releasing hormone receptor 2.
    Wan R; Guo R; Chen C; Jin L; Zhu C; Zhang Q; Xu Y; Li S
    J Cell Physiol; 2013 Jun; 228(6):1295-303. PubMed ID: 23168683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
    Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
    Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell SHP-2 negatively regulates neutrophil adhesion and promotes transmigration by enhancing ICAM-1-VE-cadherin interaction.
    Yan M; Zhang X; Chen A; Gu W; Liu J; Ren X; Zhang J; Wu X; Place AT; Minshall RD; Liu G
    FASEB J; 2017 Nov; 31(11):4759-4769. PubMed ID: 28701303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability.
    Guo M; Breslin JW; Wu MH; Gottardi CJ; Yuan SY
    Am J Physiol Cell Physiol; 2008 Apr; 294(4):C977-84. PubMed ID: 18287330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M3 muscarinic acetylcholine receptor dysfunction inhibits Rac1 activity and disrupts VE-cadherin/β-catenin and actin cytoskeleton interaction.
    Jiao ZY; Wu J; Wen B; Zhao WZ; Du XL
    Biochem Cell Biol; 2014 Apr; 92(2):137-44. PubMed ID: 24697698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
    Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression.
    Rezaei M; Friedrich K; Wielockx B; Kuzmanov A; Kettelhake A; Labelle M; Schnittler H; Baretton G; Breier G
    Breast Cancer Res; 2012 Dec; 14(6):R154. PubMed ID: 23216791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RNA-binding protein quaking maintains endothelial barrier function and affects VE-cadherin and β-catenin protein expression.
    de Bruin RG; van der Veer EP; Prins J; Lee DH; Dane MJ; Zhang H; Roeten MK; Bijkerk R; de Boer HC; Rabelink TJ; van Zonneveld AJ; van Gils JM
    Sci Rep; 2016 Feb; 6():21643. PubMed ID: 26905650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling.
    Khalfaoui-Bendriss G; Dussault N; Fernandez-Sauze S; Berenguer-Daizé C; Sigaud R; Delfino C; Cayol M; Metellus P; Chinot O; Mabrouk K; Martin PM; Ouafik L
    Oncotarget; 2015 Apr; 6(10):7536-53. PubMed ID: 25924235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells.
    Wright TJ; Leach L; Shaw PE; Jones P
    Exp Cell Res; 2002 Nov; 280(2):159-68. PubMed ID: 12413882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of VE-cadherin linkage to the cytoskeleton in endothelial cells exposed to fluid shear stress.
    Ukropec JA; Hollinger MK; Woolkalis MJ
    Exp Cell Res; 2002 Feb; 273(2):240-7. PubMed ID: 11822879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transference of recombinant VE-cadherin cytoplasmic domain alters endothelial junctional integrity and porcine microvascular permeability.
    Guo M; Wu MH; Granger HJ; Yuan SY
    J Physiol; 2004 Jan; 554(Pt 1):78-88. PubMed ID: 14678493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabotropic glutamate receptor 5 mediates phosphorylation of vascular endothelial cadherin and nuclear localization of β-catenin in response to homocysteine.
    Beard RS; Reynolds JJ; Bearden SE
    Vascul Pharmacol; 2012; 56(3-4):159-67. PubMed ID: 22285407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressing PTEN activity by tobacco smoke plus interleukin-1beta modulates dissociation of VE-cadherin/beta-catenin complexes in endothelium.
    Barbieri SS; Ruggiero L; Tremoli E; Weksler BB
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):732-8. PubMed ID: 18202321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting miR-27a/VE-cadherin interactions rescues cerebral cavernous malformations in mice.
    Li J; Zhao Y; Choi J; Ting KK; Coleman P; Chen J; Cogger VC; Wan L; Shi Z; Moller T; Zheng X; Vadas MA; Gamble JR
    PLoS Biol; 2020 Jun; 18(6):e3000734. PubMed ID: 32502201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.